BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$8.91
+0.51%
Mkt Cap $1.80B
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (12 analysts)
$14.40
Range $8.00 – $25.00
Implied Upside
+61.7%
Consensus $14.40 vs current $8.91
NASDAQ·Healthcare·Biotechnology
$8.91
+0.51%
Mkt Cap $1.80B
Buy
3
Hold
1
Sell
0
Price Target (12 analysts)
$14.40
Range $8.00 – $25.00
+61.7%
Consensus $14.40 vs current $8.91